Search Results

There are 12070 results for: content related to: Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants

  1. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 72, Issue 2, August 2011, Pages: 357–364,

    Article first published online : 11 JUL 2011, DOI: 10.1111/j.1365-2125.2011.04046.x

  2. You have free access to this content
    Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione

    British Journal of Clinical Pharmacology

    Volume 73, Issue 3, March 2012, Pages: 428–436, Karine Lacut, Estelle Ayme-Dietrich, Lenaick Gourhant, Elise Poulhazan, Marion Andro, Laurent Becquemont, Dominique Mottier, Gregoire Le Gal and Celine Verstuyft

    Article first published online : 13 FEB 2012, DOI: 10.1111/j.1365-2125.2011.04095.x

  3. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 720–725,

    Article first published online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.04094.x

  4. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 72, Issue 1, July 2011, Pages: 173–181,

    Article first published online : 9 JUN 2011, DOI: 10.1111/j.1365-2125.2011.04025.x

  5. You have free access to this content
    Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 969–977, Antje Neubert, Yingfen Hsia, Lolkje T. W. de Jong-van den Berg, Katrin Janhsen, Gerd Glaeske, Kari Furu, Helle Kieler, Mette Nørgaard, Antonio Clavenna and Ian C. K. Wong

    Article first published online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04045.x

  6. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 72, Issue 3, September 2011, Pages: 526–533,

    Article first published online : 8 AUG 2011, DOI: 10.1111/j.1365-2125.2011.04066.x

  7. You have free access to this content
    Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60–5521, a potent inhibitor of cholesteryl ester transfer protein

    British Journal of Clinical Pharmacology

    Volume 73, Issue 2, February 2012, Pages: 210–218, Michael-Friedrich Boettcher, Roland Heinig, Carsten Schmeck, Christian Kohlsdorfer, Matthias Ludwig, Anja Schaefer, Sabine Gelfert-Peukert, Georg Wensing and Olaf Weber

    Article first published online : 6 JAN 2012, DOI: 10.1111/j.1365-2125.2011.04083.x

  8. You have full text access to this OnlineOpen article
    An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 921–931, Patrick Round, Anthony Priestley and Jan Robinson

    Article first published online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04040.x

  9. You have free access to this content
    The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase

    British Journal of Clinical Pharmacology

    Volume 72, Issue 5, November 2011, Pages: 775–786, Nimish N. Vachharajani, Ralph H. Raymond, Wen-Chyi Shyu, Bruce C. Stouffer and David W. Boulton

    Article first published online : 11 OCT 2011, DOI: 10.1111/j.1365-2125.2011.04003.x

  10. You have free access to this content
    Population pharmacokinetic–pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade

    British Journal of Clinical Pharmacology

    Volume 72, Issue 3, September 2011, Pages: 415–433, Huub J. Kleijn, Daniel P. Zollinger, Michiel W. van den Heuvel and Thomas Kerbusch

    Article first published online : 8 AUG 2011, DOI: 10.1111/j.1365-2125.2011.04000.x

  11. You have free access to this content
    Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 997–1001, Natan R. Kahan, David P. Chinitz, Shimon Blackman, Dan-Andrei Waitman and Daniel A. Vardy

    Article first published online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04044.x

  12. You have free access to this content
    Prediction of a potentially effective dose in humans for BAY 60–5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling

    British Journal of Clinical Pharmacology

    Volume 73, Issue 2, February 2012, Pages: 219–231, Olaf Weber, Stefan Willmann, Hilmar Bischoff, Volkhart Li, Alexandros Vakalopoulos, Klemens Lustig, Frank-Thorsten Hafner, Roland Heinig, Carsten Schmeck and Klaus Buehner

    Article first published online : 6 JAN 2012, DOI: 10.1111/j.1365-2125.2011.04064.x

  13. You have free access to this content
    Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 932–939, Dave Singh, Sara Collarini, Gianluigi Poli, Daniela Acerbi, Alessio Amadasi and Antonio Rusca

    Article first published online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04024.x

  14. You have free access to this content
    Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses

    British Journal of Clinical Pharmacology

    Volume 73, Issue 1, January 2012, Pages: 126–134, Cynthia M. Nijenhuis, Peter G. J. ter Horst, Nienke van Rein, Bob Wilffert and Lolkje T. W. de Jong-van den Berg

    Article first published online : 8 DEC 2011, DOI: 10.1111/j.1365-2125.2011.04081.x

  15. You have free access to this content
    Drug−disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity

    British Journal of Clinical Pharmacology

    Volume 72, Issue 5, November 2011, Pages: 787–797, Forough Sanaee, John D. Clements, Alistair W. G. Waugh, Richard N. Fedorak, Richard Lewanczuk and Fakhreddin Jamali

    Article first published online : 11 OCT 2011, DOI: 10.1111/j.1365-2125.2011.04019.x

  16. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 73, Issue 6, June 2012, Pages: 1014–1027,

    Article first published online : 8 MAY 2012, DOI: 10.1111/j.1365-2125.2012.04306.x

  17. You have free access to this content
    Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor

    British Journal of Clinical Pharmacology

    Volume 74, Issue 2, August 2012, Pages: 336–345, Steve Piscitelli, Joseph Kim, Elizabeth Gould, Yu Lou, Scott White, Mark de Serres, Mark Johnson, Xiao-Jian Zhou, Keith Pietropaolo and Douglas Mayers

    Article first published online : 10 JUL 2012, DOI: 10.1111/j.1365-2125.2012.04194.x

  18. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 211–222,

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04347.x

  19. You have free access to this content
    Pharmacokinetics of linagliptin in subjects with hepatic impairment

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 75–85, Ulrike Graefe-Mody, Peter Rose, Silke Retlich, Arne Ring, Lisa Waldhauser, Rodica Cinca and Hans-Juergen Woerle

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04173.x

  20. You have free access to this content
    A unified pharmacokinetic approach to individualized drug dosing

    British Journal of Clinical Pharmacology

    Volume 73, Issue 3, March 2012, Pages: 335–339, Evan J. Begg and Paul K. L. Chin

    Article first published online : 13 FEB 2012, DOI: 10.1111/j.1365-2125.2011.04089.x